Culture accelerates and de-risks process development, process characterization, material generation, and modeling for protein therapeutics in our cloud-connected bioreactor facility. By providing scalable protein therapeutic production solutions and efficient protein expression systems, we empower biotech researchers, pharmaceutical teams, and startups to rapidly optimize their processes and achieve consistent results. With Culture, you gain access to advanced tools and expertise that streamline upstream therapeutics.
Save 6-18 months in your protein therapeutic development timeline with access to our cloud-connected bioreactor facility. Instead of dedicating time and resources to building your own lab infrastructure, focus on advancing your protein therapeutic pipeline. Our streamlined workflows and advanced systems are purpose-built to accelerate key milestones in clinic and manufacturing, helping you bring innovative therapies to market faster.
Our bioreactors are specifically designed for high-density, fed-batch microbial and mammalian upstream therapeutics processes, making them ideal for protein therapeutic development. Whether you are working on early-stage process optimization or scaling for production, our platform delivers precise control and consistency, ensuring robust and reliable upstream results. This specialized design helps biotech and pharmaceutical teams achieve superior outcomes with less effort and complexity.
Skip the time and cost of lab build-outs. Our cloud-connected bioreactors (250mL and 5L) provide on-demand fermentation capacity, while Stratyx250 enables in-house process testing for early-stage development.
We offer comprehensive expertise across a wide variety of cell lines, including CHO, HEK, yeast, and E. coli, as well as many other platforms commonly used in protein therapeutic production. Our versatile modality suites are designed to support diverse biological systems, enabling seamless adaptation to the unique requirements of your project. Whether you’re working with mammalian cells for complex protein expression or microbial systems for high-yield production, our tailored solutions ensure reliable scalability and efficiency throughout your process.
Accelerate your development timelines with our integrated protein analytics. Culture provides in-house tools such as Size Exclusion Chromatography (SEC) for detailed product attribute analysis, IgG titer measurements for rapid quality assessments, and protein mass spectroscopy to precisely characterize molecular weight and structural integrity. We also offer process monitoring capabilities, including viable cell density (VCD), pH, and metabolite tracking, to deliver real-time insights into process performance. By combining analytical precision with process expertise, we help you optimize your workflows and achieve consistent, high-quality results.
Whether you’re in preclinical development or preparing for late-phase clinical trials, we offer a full range of services to meet your specific needs. From clone screening for early-stage development to detailed process characterization for regulatory submission, our platform supports every step of your journey. With flexible, scalable solutions designed for clinical-stage protein therapeutics, efficiently navigate the complexities of process development and achieve key milestones with confidence.
Co-Founder and CEO, Geltor
.png?width=500&name=031974f5-13da-402b-a6a6-dd5b88dbde09%20(1).png)
